[ad_1]
International pharma main Lupin Limited has introduced that it has obtained approval from america Meals and Drug Administration (FDA) for its Abbreviated New Drug Utility (ANDA), lloperidone Tablets, 1 mg, 2. mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg to market a generic equal of Fanapt Tablets, 1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg of Vanda Prescribed drugs Inc.
The product shall be manufactured at Lupin’s facility in Goa, India.
lloperidone Tablets (RLD Fanapt) had estimated annual gross sales of USO 162 million within the U.S. (IQVIA MAT March 2022).
At round 12:35 PM, Lupin was buying and selling at Rs728.70 apiece up by Rs4.75 or 0.66% from its earlier closing of Rs723.95 apiece on the BSE.
[ad_2]
Source link